Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Name: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
Published: 2015
License: Public Domain

Barbara Ann Karmanos Cancer Institute · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

malignant ovarian clear cell tumor, malignant ovarian serous tumor, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, stage iiia fallopian tube cancer, stage iiia ovarian cancer, stage iiia primary peritoneal cancer, stage iiib fallopian tube cancer, stage iiib ovarian cancer, stage iiib primary peritoneal cancer, stage iiic fallopian tube cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 872646
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.